Audited Results of Sanofi India Ltd. Company

(Rs in Cr.)	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Income	2,013.20	2,851.10	2,770.10	2,956.60	2,901.90
Manufacturing Expenses	0	14.60	14.30	13.90	23.60
Personnel Expenses	240.20	370.60	405.90	433.90	460.80
Selling Expenses	0	40.90	33.80	46.20	50.20
Administrative Expenses	302.90	419.80	421.90	391.80	395.50
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,522.40	2,047.10	2,065.70	2,194.10	2,188.80
Operating Profit	490.80	804	704.40	762.50	713.10
Other Recurring Income	16.50	65.30	71.50	74.40	89.80
Adjusted PBDIT	507.30	869.30	775.90	836.90	802.90
Financial Expenses	1.50	1.70	1.70	1.80	1.80
Depreciation	36.70	39.60	41.90	66.70	82.20
Other Write offs	0	0	0	0	0
Adjusted PBT	469.10	828	732.30	768.40	718.90
Tax Charges	117.70	242.60	243.70	313.20	199.60
Adjusted PAT	351.40	585.40	488.60	455.20	519.30
Non Recurring Items	62.10	16.50	132.50	485.90	-50.50
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	413.50	603.20	620.60	944.40	477.60
Equity Dividend	0	843.20	1,573	840.60	803.80
Preference Dividend	0	0	0	0	0
Retained Earnings	413.50	601.90	843.20	1,795.10	1,694.60

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article